Reported Dec 23, 2015 · Terminated
Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by:…
Teva Pharmaceutical Industries
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Teva Pharmaceutical Industries · 20 Kiryat HaMada Street, · Jerusalem, N/A · N/A
Is this the product you have?
- Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only
- Manufactured in Israel byTEVA PHARMACEUTICAL INDUSTRIES LTD Jerusalem, 971010 Israel
- Manufactured forTEVA PHARMACEUTICAL INDUSTRIES USA Sellersville, PA 18960. NDC 0093-8238-98
- Lot codes and dates
Lot #: 24I030Exp 5/2017
- Amount recalled
- 3536 bottles
Where it was sold
- Nationwide
Why it was recalled
Labeling: Incorrect or Missing Lot AND/OR Exp Date.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Teva Pharmaceutical Industries recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.